Clinical Trials Logo

Stage II Anal Cancer AJCC v8 clinical trials

View clinical trials related to Stage II Anal Cancer AJCC v8.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05130073 Completed - Clinical trials for Anal Squamous Cell Carcinoma

4-Point Therapy Response Score With PET/CT for Anal Squamous Cell Cancer

Start date: July 31, 2019
Phase:
Study type: Observational

This study determines whether a positron emission tomography (PET)/computed tomography (CT) 4-point scoring system may predict overall survival for anal squamous cell cancer patients. A 4-point scoring system involving imaging scans may help to predict how patients with anal squamous cell cancer respond to chemoradiation therapy.

NCT ID: NCT03690921 Completed - Clinical trials for Anal Canal Squamous Cell Carcinoma

Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility Trial

Start date: November 8, 2018
Phase: Phase 2
Study type: Interventional

This phase II trial studies the side effects of LET-IMPT and standard chemotherapy, and how well they work in treating patients with newly diagnosed stage I-III anal canal squamous cell cancer. LET-IMPT is a type of radiation therapy that uses high energy proton "beamlets" to "paint" the radiation dose into the target and may help to kill tumor cells and shrink tumors. Giving LET-IMPT and standard chemotherapy may work better in treating patients with anal canal squamous cell cancer.